Trial intelligence / Profile preview

GnRH agonist versus vaginal progesterone for luteal support in modified natural-cycle frozen embryo transfer

MOH_2025-11-13_015462Phase 3Not yet recruiting

Sponsor
פרופסור עידו בן עמי
Start
Jul 2025
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, randomised, open-label trial in infertility comparing Nafarelin luteal support with Vaginal progesterone luteal support (2 arms). Primary endpoint: Pregnancy rate. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

nafarelinprogesterone
03

Conditions

infertility

Beyond the preview

Go deeper on MOH_2025-11-13_015462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2025-11-13_015462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call